Clinical Trials Directory

Trials / Conditions / Mediastinal Large B-cell Lymphoma

Mediastinal Large B-cell Lymphoma

7 registered clinical trials studyying Mediastinal Large B-cell Lymphoma.

StatusTrialSponsorPhase
CompletedAdaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T)
NCT06004167
Massachusetts General HospitalN/A
Active Not RecruitingLow Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma
NCT05621096
University of NebraskaPhase 1
Active Not RecruitingStudy of 19(T2)28z1xx TRAC-Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Lymphoma
NCT05757700
Memorial Sloan Kettering Cancer CenterPhase 1
TerminatedStudy of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocy
NCT04806035
TG Therapeutics, Inc.Phase 1
WithdrawnBrentuximab Vedotin, Bendamustine, and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Ly
NCT02623920
University of ArizonaPhase 2
CompletedStudy of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell
NCT02576990
Merck Sharp & Dohme LLCPhase 2
CompletedACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies
NCT02362035
Acerta Pharma BVPhase 1 / Phase 2